Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Standiford

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Infection Control : IC|May 1, 1987
Methicillin-resistant Staphylococcus aureus infections: it's time to get toughH C Standiford
Pharmacotherapy|July 1, 1982
A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacyB J Fitzpatrick, H C Standiford
The American Journal of Medicine|June 7, 1985
Pharmacokinetic profile of imipenem/cilastatin in normal volunteersG L Drusano, H C Standiford
European Journal of Clinical Microbiology|February 1, 1986
Technical aspects and clinical correlations of the serum bactericidal testH C Standiford, B A Tatem
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 1998
Facet and facet-joint infections: case report and reviewT Louie, B Morgan, H C Standiford
American Journal of Infection Control|February 1, 1987
Accuracy of patient recall for date of peripheral intravenous catheter insertionD Vlahov, K W Cervino, H C Standiford
The Journal of Infectious Diseases|September 1, 1970
Carbenicillin in treatment of severe infections due to pseudomonasM C Jordan, H C Standiford, W M Kirby
Chemotherapy|January 1, 1985
Latamoxef in combination with aminoglycosides against Pseudomonas aeruginosa: similarity with ticarcillinS D Sears, B A Tatem, H C Standiford
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosaB S Margaret, G L Drusano, H C Standiford
European Journal of Cancer & Clinical Oncology|August 1, 1984
Role of antimicrobial synergism in infected granulocytopenic patientsH C Standiford, D E Johnson, S C Schimpff
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Infection Control : IC|May 1, 1987
Methicillin-resistant Staphylococcus aureus infections: it's time to get toughH C Standiford
Pharmacotherapy|July 1, 1982
A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacyB J Fitzpatrick, H C Standiford
The American Journal of Medicine|June 7, 1985
Pharmacokinetic profile of imipenem/cilastatin in normal volunteersG L Drusano, H C Standiford
European Journal of Clinical Microbiology|February 1, 1986
Technical aspects and clinical correlations of the serum bactericidal testH C Standiford, B A Tatem
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 1998
Facet and facet-joint infections: case report and reviewT Louie, B Morgan, H C Standiford
American Journal of Infection Control|February 1, 1987
Accuracy of patient recall for date of peripheral intravenous catheter insertionD Vlahov, K W Cervino, H C Standiford
The Journal of Infectious Diseases|September 1, 1970
Carbenicillin in treatment of severe infections due to pseudomonasM C Jordan, H C Standiford, W M Kirby
Chemotherapy|January 1, 1985
Latamoxef in combination with aminoglycosides against Pseudomonas aeruginosa: similarity with ticarcillinS D Sears, B A Tatem, H C Standiford
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosaB S Margaret, G L Drusano, H C Standiford
European Journal of Cancer & Clinical Oncology|August 1, 1984
Role of antimicrobial synergism in infected granulocytopenic patientsH C Standiford, D E Johnson, S C Schimpff
Pageof 8